DOI: 10.5281/zenodo.4612274
title: MESINESP2 Corpora: Annotated data for medical semantic indexing in Spanish

description: Gold Standard annotations of the MESINESP2 corpora (training, development and test sets). <strong>Please cite this paper if you use this dataset:</strong> <pre><code class="language-bash">@inproceedings{gasco2021overview, title={Overview of BioASQ 2021-MESINESP track. Evaluation of advance hierarchical classification techniques for scientific literature, patents and clinical trials}, author={Gasco, Luis and Nentidis, Anastasios and Krithara, Anastasia and Estrada-Zavala, Darryl and Murasaki, Renato Toshiyuki and Primo-Pe{\~n}a, Elena and Bojo Canales, Cristina and Paliouras, Georgios and Krallinger, Martin and others}, year={2021}, organization={CEUR Workshop Proceedings} }</code></pre> <strong>Introduction</strong> The main aim of MESINESP2 is to promote the development of practically relevant semantic indexing tools for biomedical content in non-English language. We have generated a manually annotated corpus, where domain experts have labeled a set of scientific literature, clinical trials, and patent abstracts. All the documents were labeled with DeCS descriptors, which is a structured controlled vocabulary created by BIREME to index scientific publications on BvSalud, the largest database of scientific documents in Spanish, which hosts records from the databases LILACS, MEDLINE, IBECS, among others. MESINESP track at BioASQ9 explores the efficiency of systems for assigning DeCS to different types of biomedical documents. To that purpose, we have divided the task into three subtracks depending on the document type. Then, for each one we generated an annotated corpus which was provided to participating teams: <strong>[Subtrack 1 corpus] MESINESP-L – Scientific Literature: </strong>It contains all Spanish records from LILACS and IBECS databases at the Virtual Health Library (VHL) with non-empty abstract written in Spanish. <strong>[Subtrack 2 corpus] <strong>MESINESP-T- Clinical Trials </strong></strong>contains records from Registro Español de Estudios Clínicos (REEC). REEC doesn't provide documents with the structure title/abstract needed in BioASQ, for that reason we have built artificial abstracts based on the content available in the data crawled using the REEC API. <strong>[Subtrack 3 corpus] MESINESP-P – Patents: </strong>This corpus includes patents in Spanish extracted from Google Patents which have the IPC code “A61P” and “A61K31”. In addition, we also provide a set of complementary data such as: the DeCS terminology file, a silver standard with the participants' predictions to the task background set and the entities of medications, diseases, symptoms and medical procedures extracted from the BSC NERs documents. <strong>Files structure:</strong> <strong>Silver_Standard_Mesinesp2.zip </strong>contains two separate sections. On the one hand, the union of the labels of the best model of each participating team as long as this model had obtained at least an F-score of 0.2 (folder <em>join</em>). On the other hand, the predictions of the best models of each participant have been included individually and anonymized (folder <em>separated</em>). This silver standard contains a set of <em>8642 scientific articles</em>, <em>1537 text sections from Clinical Practice Guidelines</em>, a set of <em>8458 text segments from Medication Data Sheets</em>, <em>461 clinical trials from REEC and 5170 patents</em>. <strong>Subtrack1-Scientific_Literature.zip</strong> contains the corpora generated for subtrack 1. Content: Subtrack1: Train: training_set_track1_all.json: Full training set for subtrack 1. training_set_track1_only_articles.json: Articles training set for subtrack 1. Development development_set_subtrack1.json: Test test_set_subtrack1.json: Test set for subtrack 1. <strong>Subtrack2-Clinical_Trials.zip</strong> contains the corpora generated for subtrack 2. Content: Subtrack2: Train training_set_subtrack2.json: Training set for subtrack 2. Development development_set_subtrack2.json: Manually annotated development set for subtrack 2. Test test_set_subtrack2.json: Test set for subtrack 2. <strong>Subtrack3-Patents.zip</strong> contains the corpora generated for subtrack 3. Content: Subtrack3: Development development_set_subtrack3.json: Manually annotated development set for subtrack 3. Test test_set_subtrack3.json: Test set for subtrack 3. <strong>Additional data.zip </strong>contains the corpora with additional data for each subtrack of MESINESP2. <strong>DeCS2020.tsv</strong> contains a DeCS table with the following structure: DeCS code Preferred descriptor (the preferred label in the Latin Spanish DeCS 2020 set) List of synonyms (the descriptors and synonyms from Latin Spanish DeCS 2020 set, separated by pipes. <strong>DeCS2020.obo </strong>contains the *.obo file with the hierarchical relationships between DeCS descriptors. *Note: The <em>obo </em>and <em>tsv </em>files with DeCS2020 descriptors contain some additional COVID19 descriptors that will be included in future versions of DeCS. These items were provided by the Pan American Health Organization (PAHO), which has kindly shared this content to improve the results of the task by taking these descriptors into account. <strong>Data format description</strong> The <strong>input text files</strong> for the MESINESP track are JSON files with the following structure: <pre><code class="language-json">{ "articles": [ { "id": "ibc-FGT-907", "title": "Metas de control de la presión arterial e impacto sobre desenlaces cardiovasculares en pacientes con diabetes mellitus tipo 2: un análisis crítico de la literatura", "abstractText": "La hipertensión arterial en individuos con diabetes mellitus tipo2 incrementa el riesgo de eventos cardiovasculares. Las guías internacionales de manejo recomiendan iniciar tratamiento farmacológico con valores de presión arterial &gt;140/90mmHg Sin embargo, no existe un punto de corte óptimo a partir del cual se logre reducir los eventos cardiovasculares sin originar eventos adversos; un rango de presión arterial &gt;130/80 y &lt;140/90mmHg parece ser el adecuado. Estos valores pueden alcanzarse mediante intervenciones no farmacológicas (dieta, ejercicio) y farmacológicas (por fármacos que hayan demostrado reducir eventos cardiovasculares). La elección de uno o varios fármacos debe ser individualizada, de acuerdo con factores como etnia, edad, comorbilidades asociadas, entre otros", "journal": "Clín. investig. arterioscler. (Ed. impr.)", "year": 2019, "db": "IBECS", "decsCodes": [ "D006973", "D000959", "D002318", "D003924", "D012307" ] } ] }</code></pre> MESINESP <strong>entity mention files</strong> contain automatically generated mention annotations of medications, diseases, syntoms and medical procedures with the following JSON format: <pre><code class="language-json">{ "articles": [ { "id": "ibc-FGT-907", "diseases": [ {"span": "hipertensión arterial", "start": "3", "end": "24"}, {"span": "diabetes mellitus tipo2", "start": "43", "end": "66"}, {"span": "eventos cardiovasculares", "start": "91", "end": "115"}], "medications": [], "procedures": [], "symptoms": []}] } ] }</code></pre> <strong>Dataset description:</strong><br> These corpora contain the data for each of the subtracks of MESINESP2 shared-task: <strong>[Subtrack 1] MESINESP-L – Scientific Literature </strong>: <em><strong>Training set: </strong></em>It contains all spanish records from LILACS and IBECS databases at the Virtual Health Library (VHL) with non-empty abstract written in Spanish. We have filtered out empty abstracts and non-Spanish abstracts. We have built the training dataset with the data crawled on 01/29/2021. This means that the data is a snapshot of that moment and that may change over time since LILACS and IBECS usually add or modify indexes after the first inclusion in the database. We distribute two different datasets: <strong>Articles training set: </strong>This corpus contains the set of 237574 Spanish scientific papers in VHL that have at least one DeCS code assigned to them. <strong>Full training set</strong>: This corpus contains the whole set of 249474 Spanish documents from VHL that have at leas one DeCS code assigned to them. <strong>Development set: </strong>We provided a development set manually indexed by our expert annotators (not VHL ones). This dataset includes 1065 articles annotated with DeCS by three expert indexers in this controlled vocabulary. The articles were initially indexed by 7 annotators, after analyzing the Inter-Annotator Agreement among their annotations we decided to select the 3 best ones, considering their annotations the valid ones to build the test set. From those 1065 records: 213 articles were annotated by more than one annotator. We have selected de union between annotations. 852 articles were annotated by only one of the three selected annotators with better performance. <strong>Test set:</strong> We provide a test set containing 491 abstracts from LILACS and IBECS. We used this subset to evaluate the participating systems. <strong>[Subtrack 2] <strong>MESINESP-T- Clinical Trials</strong></strong>: <strong>Training set: </strong>The training dataset contains records from Registro Español de Estudios Clínicos (REEC). REEC doesn't provide documents with the structure title/abstract needed in BioASQ, for that reason we have built artificial abstracts based on the content available in the data crawled using the REEC API. Clinical trials are not indexed with DeCS terminology, we have used as training data a set of 3560 clinical trials that were automatically annotated in the first edition of MESINESP and that were published as a Silver Standard outcome. Because the performance of the models used by the participants was variable, we have only selected predictions from runs with a MiF higher than 0.41, which corresponds with the submission of the best team. <strong>Development set: </strong>We provide a development set manually indexed by expert annotators. This dataset includes 147 clinical trials annotated with DeCS by seven expert indexers in this controlled vocabulary. <strong>Test set: </strong>The test dataset contains a collection of 248 items. We used this subset to evaluate the participating systems. <strong>[Subtrack 3] MESINESP-P – Patents: </strong> <strong>Development set: </strong>We provide a Development set manually indexed by expert annotators. This dataset includes 115 patents in Spanish extracted from Google Patents which have the IPC code “A61P” and “A61K31”. We have selected these patents based on semantic similarity to the MESINESP-L training set to facilitate model generation and to try to improve model performance. <strong>Test set: </strong>We provide a <strong>test set</strong> containing 119 records that correspond to a subset of patents published in Spanish with the IPC codes “A61P” and “A61K31”.Similarly to the development set, we selected these records based on semantic similarity to the MESINESP-L training set. We used this subset to evaluate the participating systems. <strong>Additional data:</strong> We provide this information to the participants as additional data in the “Additional Data” folder. For each training, development, and test set there is an additional JSON file with the structure shown here. Each file contains entities related to medications, diseases, symptoms, and medical procedures extrated with the BSC NERs. <strong>Summary statistics:</strong> MESINESP Corpus statistics MESINESP-L Docs DeCS Unique DeCS Tokens Training 237574 1988684 22434 43106663 Development 1065 11283 3750 211420 Test 491 5398 2124 93645 <em>Total</em> 239130 2005365 22482 43411728 MESINESP-T Training 3560 52257 3940 4133166 Development 147 2038 771 146791 Test 248 3271 905 267031 <em>Total</em> 3955 57566 4410 4546988 MESINESP-P Development 109 1092 520 38564 Test 119 1176 629 9065 <em>Total</em> 228 2268 989 47629 General MESINESP Corpus statistics MESINESP Docs DeCS Unique DeCS Tokens MESINESP-L 239130 2005365 22482 43411728 MESINESP-T 3955 57566 4410 4546988 MESINESP-P 228 2268 989 47629 <em>Total</em> 243313 2065199 22641 48006345 <strong>Related resources:</strong> MESINESP2 Web Evaluation library Annotation guidelines Participating teams Youtube Videos Proceedings of BioASQ@CLEF2021 BioASQ Web For further information, please email us at luis.gasco@bsc.es
description: Funded by the Plan de Impulso de las Tecnologías del Lenguaje (Plan TL).